Allarity Therapeutics, Inc. Annual Income Tax Expense (Benefit) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Allarity Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
  • Allarity Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$377K.
  • Allarity Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $83K.
  • Allarity Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was -$1.52M, a 1244% decline from 2021.
  • Allarity Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $133K, a 32.8% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $83K +$1.6M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-08
2022 -$1.52M -$1.65M -1244% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 $133K -$65K -32.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-13
2020 $198K Jan 1, 2020 Dec 31, 2020 10-K 2022-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.